Youssef Gamal
AA, Sadek HS, Eid GEM. Postoperative Pain and Matrix Metalloproteinase-9 Pulpal
Blood Level in Symptomatic Pulpitis of Mature Molars Treated with Biodentine
and Portland Cement Full Pulpotomy: A Randomized Clinical Trial. J Clin Exp
Dent. 2026;18(6):e792-807.
doi:10.4317/jced.64138
https://doi.org/10.4317/jced.64138
___
References
|
1.
Duncan HF, Galler KM, Tomson PL, Simon S, El-Karim I, Kundzina R, et al.
European Society of Endodontology position statement: Management of deep
caries and the exposed pulp. Int Endod J. 2019;52(7):923-34. |
|
|
|
|
|
2.
American Association of Endodontists Special Committee on Vital Pulp Therapy.
AAE position statement on vital pulp therapy. J Endod. 2021;47(9):1340-44. |
|
|
|
|
|
3.
Alqaderi H, Lee CT, Borzangy S, Pagonis TC. Coronal pulpotomy for cariously
exposed permanent posterior teeth with closed apices: a systematic review and
meta-analysis. J Dent. 2016;44:1-7. |
|
|
|
|
|
4.
Zhu L, Liu W, Deng X, Chen Z, Chen J, Qian W. Full pulpotomy versus root canal
therapy in mature teeth with irreversible pulpitis: a randomized controlled
trial. BMC Oral Health. 2024;24(1):1231. |
|
|
|
|
|
5.
Altunbas D, Ayhan M, Bilgin O. Evaluation of postoperative pain relief after
pulpotomy using different procedures for disinfection and hemostasis in
symptomatic irreversible pulpitis. Niger J Clin Pract. 2023;26(6):819-24. |
|
|
|
|
|
6.
Qudeimat MA, Alyahya A, Hasan AA. Mineral trioxide aggregate pulpotomy for
permanent molars with clinical signs indicative of irreversible pulpitis: a
preliminary study. Int Endod J. 2017;50(2):126-34. |
|
|
|
|
|
7.
Kumar V, Juneja R, Duhan J, Sangwan P, Tewari S. Comparative evaluation of
platelet-rich fibrin, mineral trioxide aggregate, and calcium hydroxide as
pulpotomy agents in permanent molars with irreversible pulpitis: a randomized
controlled trial. Contemp Clin Dent. 2016;7(4):512-18. |
|
|
|
|
|
8.
Galani M, Tewari S, Sangwan P, Mittal S, Kumar V, Duhan J. Comparative
evaluation of postoperative pain and success rate after pulpotomy and root canal
treatment in cariously exposed mature permanent molars: a randomized
controlled trial. J Endod. 2017;43(12):1953-62. |
|
|
|
|
|
9.
Awawdeh L, Al-Qudah A, Hamouri H, Chakra RJ. Outcomes of vital pulp therapy
using mineral trioxide aggregate or Biodentine: a prospective randomized
clinical trial. J Endod. 2018;44(11):1603-9. |
|
|
|
|
|
10.
Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult
patients with symptoms indicative of irreversible pulpitis. Int Endod J.
2018;51(8):819-28. |
|
|
|
|
|
11.
Tan SY, Yu VSH, Lim KC, Tan BCK, Neo CLJ, Shen L, et al. Long-term pulpal and
restorative outcomes of pulpotomy in mature permanent teeth. J Endod.
2020;46(3):383-90. |
|
|
|
|
|
12.
Li Y, Sui B, Dahl C, Bergeron B, Shipman P, Niu L, et al. Pulpotomy for carious
pulp exposures in permanent teeth: a systematic review and meta-analysis. J
Dent. 2019;84:1-8. |
|
|
|
|
|
13.
Anta S, Diouma N, Ousmane NS, Fatou LB, Florence F, Babacar T. Evaluation of
complete pulpotomy with Biodentine on mature permanent molars with signs and
symptoms of symptomatic irreversible pulpitis: 12-month follow-up. J Endod.
2022;48(3):312-19. |
|
|
|
|
|
14.
Asgary S, Eghbal MJ, Shahravan A, Saberi E, Baghban AA, Parhizkar A. Outcomes
of root canal therapy or full pulpotomy using two endodontic biomaterials in
mature permanent teeth: a randomized controlled trial. Clin Oral Investig.
2022;26(3):3287-97. |
|
|
|
|
|
15.
Ramani A, Sangwan P, Tewari S, Duhan J, Mittal S, Kumar V. Comparative
evaluation of complete and partial pulpotomy in mature permanent teeth with
symptomatic irreversible pulpitis: a randomized clinical trial. Int Endod J.
2022;55(5):430-40. |
|
|
|
|
|
16.
Silva EJNL, Pinto KP, Riche FNSJ, Carestiato MGH, Martins JNR, Duncan HF, et al.
A meta-analysis of calcium silicate-based cements and calcium hydroxide as
promoters of hard tissue bridge formation. Int Endod J. 2025;58(5):685-714. |
|
|
|
|
|
17.
Gerihan HE, Çoğulu D, Önçağ Ö, Durmaz A, Kuru EH. Assessment of MMP levels in
reversible and irreversible pulpitis and a randomized controlled trial
comparing clinical success of two different calcium-silicate cements in
pulpotomy treatment of primary molars with an 18-month follow-up. BMC Oral
Health. 2024;24(1):1020. |
|
|
|
|
|
18.
Abdelaziz MS, Abdelsalam N, Fayyad DM. Assessment of the number of missing
tooth surfaces and the molecular findings on the outcomes of vital pulp
therapy using 2 calcium silicate materials: a randomized clinical study. J
Endod. 2025;51(6):658-65. |
|
|
|
|
|
19.
Patel N, Khan I, Jarad F, Zavattini A, Koller G, Pimentel T, et al. The
short-term postoperative pain and impact upon quality of life of pulpotomy
and root canal treatment, in teeth with symptoms of irreversible pulpitis: a
randomized controlled clinical trial. Int Endod J. 2025;58(1):55-70. |
|
|
|
|
|
20.
Sarı M, Yılmaz K, Özyürek T. Postoperative pain after total pulpotomy and
root canal treatment in mature molars according to the new and traditional classifications
of pulpitis: a prospective, randomized controlled trial. BMC Oral Health.
2024;24(1):1075. |
|
|
|
|
|
21.
Louzada LM, Hildebrand H, Neuhaus KW, Duncan HF. The effectiveness of partial
pulpotomy compared with full pulpotomy in managing deep caries in vital
permanent teeth with a diagnosis of non-traumatic pulpitis. Int Endod J.
2025;58(1):37-54. |
|
|
|
|
|
22.
Çelikkol B, Kuru HE. Postoperative pain and its relationship with
patient-related factors after vital pulpotomy in teeth with symptomatic
pulpitis: a prospective clinical study. Med Princ Pract. 2025;34(6):575-82. |
|
|
|
|
|
23.
Alhilou AM, Al-Moraissi EA, Bakhsh A, Christidis N, Näsman P. Pain after
emergency treatments of symptomatic irreversible pulpitis and symptomatic
apical periodontitis in the permanent dentition: a systematic review of
randomized clinical trials. Front Oral Health. 2023;4:1147884. |
|
|
|
|
|
24.
Fasoulas A, Keratiotis G, Spineli L, Pandis N, De Bruyne MAA, De Moor RJG, et
al. Comparative efficacy of materials used in patients undergoing pulpotomy
or direct pulp capping in carious teeth: a systematic review and
meta-analysis. Clin Exp Dent Res. 2023;9(6):1129-48. |
|
|
|
|
|
25.
Cassiano Ferraz D, Garuba Rahhal J, Paz Dotto ME, Alberti Ferreira L, Sipert
CR, Letra A, et al. Physicochemical and biological properties of Biodentine
XP, Endosequence RRM, and Bio-C repair cements. J Endod. 2025;51(8):1109-17. |
|
|
|
|
|
26.
Andrei M, Vacaru RP, Coricovac A, Ilinca R, Didilescu AC, Demetrescu I. The
effect of calcium-silicate cements on reparative dentinogenesis following
direct pulp capping on animal models. Molecules. 2021;26(9):2725. |
|
|
|
|
|
27.
Estrela C, Bammann LL, Estrela CR, Silva RS, Pécora JD. Antimicrobial and
chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and
Dycal. Braz Dent J. 2000;11(1):3-9. |
|
|
|
|
|
28.
Danesh G, Dammaschke T, Gerth HU, Zandbiglari T, Schäfer E. A comparative
study of selected properties of ProRoot mineral trioxide aggregate and two
Portland cements. Int Endod J. 2006;39(3):213-9. |
|
|
|
|
|
29.
Min KS, Kim HI, Park HJ, Pi SH, Hong CU, Kim EC. Human pulp cells response to
Portland cement in vitro. J Endod. 2007;33(2):163-6. |
|
|
|
|
|
30.
Islam I, Chng HK, Yap AU. Comparison of the physical and mechanical
properties of MTA and portland cement. J Endod. 2006;32(3):193-7. |
|
|
|
|
|
31.
Monteiro Bramante C, Demarchi AC, de Moraes IG, Bernadineli N, Garcia RB,
Spångberg LS, et al. Presence of arsenic in different types of MTA and white
and gray Portland cement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2008;106(6):909-13. |
|
|
|
|
|
32.
Yoshino P, Nishiyama CK, Modena KC, Santos CF, Sipert CR. In vitro
cytotoxicity of white MTA, MTA Fillapex® and Portland cement on human
periodontal ligament fibroblasts. Braz Dent J. 2013;24(2):111-6. |
|
|
|
|
|
33.
Sakai VT, Moretti AB, Oliveira TM, Fornetti AP, Santos CF, Machado MA, Abdo
RC. Pulpotomy of human primary molars with MTA and Portland cement: a
randomised controlled trial. Br Dent J. 2009;207(3):128-9. |
|
|
|
|
|
34.
Petrou MA, Alhamoui FA, Welk A, Altarabulsi MB, Alkilzy M, H Splieth C. A
randomized clinical trial on the use of medical Portland cement, MTA and
calcium hydroxide in indirect pulp treatment. Clin Oral Investig.
2014;18(5):1383-9. |
|
|
|
|
|
35.
Maroto M, Barreiro S, Barbería E. Portland cement as pulp dressing agent in
pulpotomy treatment of primary molars: a 12-month clinical study. Eur J
Paediatr Dent. 2019;20(1):23-6. |
|
|
|
|
|
36.
Kearney M, Cooper PR, Smith AJ, Duncan HF. Epigenetic approaches to the
treatment of dental pulp inflammation and repair: opportunities and
obstacles. Front Genet. 2018;9:311. |
|
|
|
|
|
37.
Ballal NV, Duncan HF, Wiedemeier DB, Rai N, Jalan P, Bhat V, et al. MMP-9
levels and NaOCl lavage in randomized trial on direct pulp capping. J Dent
Res. 2022;101(4):414-19. |
|
|
|
|
|
38.
Hirsch V, Wolgin M, Mitronin AV, Kielbassa AM. Inflammatory cytokines in
normal and irreversibly inflamed pulps: a systematic review. Arch Oral Biol.
2017;82:38-46. |
|
|
|
|
|
39.
Emilia E, Neelakantan P. Biomarkers in the dentin-pulp complex: role in
health and disease. J Clin Pediatr Dent. 2015;39(2):94-9. |
|
|
|
|
|
40.
Rechenberg DK, Galicia JC, Peters OA. Biological markers for pulpal
inflammation: a systematic review. PLoS One. 2016;11(11):e0167289. |
|
|
|
|
|
41.
Zanini M, Meyer E, Simon S. Pulp inflammation diagnosis from clinical to
inflammatory mediators: a systematic review. J Endod. 2017;43(7):1033-51. |
|
|
|
|
|
42.
Karrar RN, Cushley S, Duncan HF, Lundy FT, Abushouk SA, Clarke M, et al.
Molecular biomarkers for objective assessment of symptomatic pulpitis: a
systematic review and meta-analysis. Int Endod J. 2023;56(10):1160-77. |
|
|
|
|
|
43.
Mente J, Petrovic J, Gehrig H, Rampf S, Michel A, Schürz A, et al. A
prospective clinical pilot study on the level of matrix metalloproteinase-9
in dental pulpal blood as a marker for the state of inflammation in the pulp
tissue. J Endod. 2016;42(2):190-7. |
|
|
|
|
|
44.
Sharma R, Kumar V, Logani A, Chawla A, Mir RA, Sharma S, Kalaivani M.
Association between concentration of active MMP-9 in pulpal blood and
pulpotomy outcome in permanent mature teeth with irreversible pulpitis: a
preliminary study. Int Endod J. 2021;54(4):479-89. |
|
|
|
|
|
45.
Sirintawat N, Sawang K, Chaiyasamut T, Wongsirichat N. Pain measurement in oral
and maxillofacial surgery. J Dent Anesth Pain Med. 2017;17(4):253-63. |
|
|
|
|
|
46.
Eghbal MJ, Haeri A, Shahravan A, Kazemi A, Moazami F, Mozayeni MA, et al.
Postendodontic pain after pulpotomy or root canal treatment in mature teeth
with carious pulp exposure: a multicenter randomized controlled trial. Pain
Res Manag. 2020;2020:5853412 |
|
|
|
|
|
47.
Taha NA, Albakri SW. Outcome and prognostic factors for partial and full
pulpotomy in the management of spontaneous symptomatic pulpitis in carious
mature permanent teeth: a randomized clinical trial. J Endod.
2024;50(7):889-98. |
|
|
|
|
|
48.
Camilleri J, Montesin FE, Curtis RV, Ford TR. Characterization of Portland
cement for use as a dental restorative material. Dent Mater.
2006;22(6):569-75. |
|
|
|
|
|
49.
Ravi KS, Vanka A. Portland cement: A building of evidence for clinical use.
Int J Dent Clin. 2011;3(1):52-5. |
|
|
|
|
|
50.
Oliveira MG, Xavier CB, Demarco FF, Pinheiro AL, Costa AT, Pozza DH. Comparative
chemical study of MTA and Portland cements. Braz Dent J. 2007;18(1):3-7. |
|
|
|
|
|
51.
Ishwarya R, Arangannal P, Amudha S, Vijayakumar M. Portland cement: an
effective and cheap alternative to MTA. Eur J Mol Clin Med. 2020;7:6502-8. |
|
|
|
|
|
52.
Nosrat IV, Nosrat CA. Reparative hard tissue formation following calcium
hydroxide application after partial pulpotomy in cariously exposed pulps of
permanent teeth. Int Endod J. 1998;31(3):221-6. |
|
|
|
|
|
53.
Taha NA, Al-Rawash MH, Imran ZA. Outcome of full pulpotomy in mature
permanent molars using 3 calcium silicate-based materials: a parallel, double
blind, randomized controlled trial. Int Endod J. 2022;55(5):416-42. |
|
|
|
|
|
54.
Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR. Inhibitors of
prostaglandin synthesis inhibit human prostate tumor cell invasiveness and
reduce the release of matrix metalloproteinases. Cancer Res.
2000;60(16):4629-37. |
|
|
|
|
|
55.
Zara S, Rapino M, Sozio P, Di Stefano A, Nasuti C, Cataldi A. Ibuprofen and
lipoic acid codrug 1 control Alzheimer's disease progression by
down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels
in β-amyloid infused Alzheimer's disease rat model. Brain Res.
2011;1412:79-87. |
|
|
|
|
|
56.
Komora P, Vámos O, Gede N, Hegyi P, Kelemen K, Galvács A, et al. Comparison
of bioactive material failure rates in vital pulp treatment of permanent
matured teeth: a systematic review and network meta-analysis. Sci Rep.
2024;14(1):18421. |
|
|
|
|
|
57.
Albatal S, Kouchaji C, Al-Akkad M, Mounajjed R. Pulpotomy using Portland
cement in mature permanent teeth with irreversible pulpitis. Stomatológ.
2021;31:46-51. |
|
|
|
|
|
58.
Abed D, Bchara J, Bshara N. Vital pulpotomy on immature lower first permanent
molars using Portland cement, a case of failure and success-case report with 2 years
follow-up. Clin Case Rep. 2023;11(4):e7272. |
|
|
|
|
|
59.
Aminabadi NA, Parto M, Emamverdizadeh P, Jamali Z, Shirazi S. Pulp bleeding
color is an indicator of clinical and histohematologic status of primary
teeth. Clin Oral Investig. 2017;21(5):1831-41. |
|
|
|
|
|
60.
Cushley S, Duncan HF, Lappin MJ, Tomson PL, Lundy FT, Cooper P, et al.
Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: a systematic
review. J Dent. 2019;88:103158. |
|
|
|
|
|
61.
Ehrmann EH, Messer HH, Adams GG. The relationship of intracanal medicaments
to postoperative pain in endodontics. Int Endod J. 2003;36(12):868-75. |
|
|
|
|
|
62.
Bashetty K, Hegde J. Comparison of 2% chlorhexidine and 5.25% sodium
hypochlorite irrigating solutions on postoperative pain: a randomized
clinical trial. Indian J Dent Res. 2010;21(4):523-7. |
|
|
|
|
|
63.
Taha NA, Abuzaid AM, Khader YS. A randomized controlled clinical trial of
pulpotomy versus root canal therapy in mature teeth with irreversible
pulpitis: outcome, quality of life, and patients' satisfaction. J Endod.
2023;49(6):624-31.e2. |
|
|
|
|
|
64.
Galler KM, Weber M, Korkmaz Y, Widbiller M, Feuerer M. Inflammatory response
mechanisms of the dentine-pulp complex and the periapical tissues. Int J Mol
Sci. 2021;22(3):1480. |
|
|
|
|
|
65.
Kot K, Kucharski Ł, Marek E, Safranow K, Lipski M. Alkalizing properties of
six calcium-silicate endodontic biomaterials. Materials (Basel).
2022;15(18):6482. |
|
|
|
|
|
66.
Duarte MAH, Marciano MA, Vivan RR, Tanomaru Filho M, Tanomaru JMG, Camilleri
J. Tricalcium silicate-based cements: properties and modifications. Braz Oral
Res. 2018;32(suppl 1):e70. |
|
|
|
|
|
67.
Lin YY, Zhang P, Cheon K, Jackson JG, Lawson NC. Chemical and physical
properties of contemporary pulp capping materials. Pediatr Dent.
2022;44(3):207-12. |
|
|
|
|
|
68.
Coaguila-Llerena H, Ochoa-Rodriguez VM, Castro-Núñez GM, Faria G,
Guerreiro-Tanomaru JM, Tanomaru-Filho M. Physicochemical properties of a
bioceramic repair material - BioMTA. Braz Dent J. 2020;31(5):511-15. |
|
|
|
|
|
69.
Bassam S, El-Ahmar R, Salloum S, Ayoub S. Endodontic postoperative flare-up:
an update. Saudi Dent J. 2021;33(7):386-94. |
|
|
|
|
|
70.
Jang YE, Kim Y, Kim BS. Influence of preoperative mechanical allodynia on predicting
postoperative pain after root canal treatment: a prospective clinical study.
J Endod. 2021;47(5):770-8. |
|
|
|
|
|
71.
Tenório de Franca TR, da Silva RJ, Sedycias de Queiroz M, Aguiar CM. Arsenic
content in Portland cement: a literature review. Indian J Dent Res.
2010;21(4):591-5. |
|